4//SEC Filing
HALBERT DAVID D 4
Accession 0001104659-25-061808
CIK 0002019410other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:33 PM ET
Size
16.8 KB
Accession
0001104659-25-061808
Insider Transaction Report
Form 4
HALBERT DAVID D
DirectorSee Remarks10% Owner
Transactions
- Award
Common Stock
2025-03-25+360,750→ 2,023,250 total - Award
Common Stock
2025-06-18+413,839→ 2,437,089 total - Conversion
Common Stock
2025-06-20+104,761,535→ 121,025,002 total(indirect: See Footnotes) - Conversion
Series A Preferred Stock
2025-06-20−389,416,484→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (97,354,127 underlying) - Conversion
Series B Preferred Stock
2025-06-20−29,629,630→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (7,407,408 underlying)
Caris Halbert, L.P.
Director10% Owner
Transactions
- Award
Common Stock
2025-03-25+360,750→ 2,023,250 total - Conversion
Common Stock
2025-06-20+104,761,535→ 121,025,002 total(indirect: See Footnotes) - Conversion
Series A Preferred Stock
2025-06-20−389,416,484→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (97,354,127 underlying) - Conversion
Series B Preferred Stock
2025-06-20−29,629,630→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (7,407,408 underlying) - Award
Common Stock
2025-06-18+413,839→ 2,437,089 total
Footnotes (6)
- [F1]Represents an award of restricted stock units that vest in accordance with the applicable grant agreement. These restricted stock units were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025.
- [F2]Represents an award of restricted stock units that vest in accordance with the applicable grant agreement.
- [F3]Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock.
- [F4]The Common Stock reported herein includes (i) 101,261,532 shares of Common Stock held of record by Caris Halbert, L.P, (ii) 8,528,805 shares of Common Stock held of record by ADAPT I Ltd., (iii) 8,414,427 shares of Common Stock held of record by Carisome I, L.P., (iv) 645,149 shares of Common Stock held of record by Caris Investment II Ltd, and (v) 2,175,089 shares of Common Stock held of record by Caris Investment III Ltd. Caris Investment Management, LLC is the general partner of each of Caris Halbert, L.P., Caris Investment II Ltd., and Caris Investment III Ltd. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively.
- [F5]David D. Halbert is the managing member of Caris Investment Management, LLC and the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F6]The preferred stock reported herein includes (i) 3,500,003 shares of Common Stock underlying Series A Preferred Stock held of record by ADAPT I Ltd., (ii) 93,854,124 shares of Common Stock underlying Series A Preferred Stock held of record by Caris Halbert, L.P. and (iii) 7,407,408 shares of Common Stock underlying Series B Preferred Stock held of record by Caris Halbert, L.P.
Documents
Issuer
Caris Life Sciences, Inc.
CIK 0002019410
Entity typeother
Related Parties
1- filerCIK 0001034380
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 6:33 PM ET
- Size
- 16.8 KB